mRNA technology and lipid nanoparticle (LNP) delivery systems have revolutionized vaccine development and other therapeutic applications. Whether you are in research, development, or manufacturing, our comprehensive portfolio of products, services, contract development and manufacturing capabilities, and expertise provides everything you need for mRNA synthesis, purification, and formulation. By partnering with us, you can expect direct and flexible interactions and technical support anywhere along your mRNA molecule’s journey.
mRNA technologies offer a simplified manufacturing process, which uses the same reaction materials and vessels for any target. This allows GMP facilities to switch to a new protein target within very short time periods and with minimal adaptation to process and formulation. In our technical article, "Manufacturing Strategies for mRNA Vaccines and Therapeutics" we discuss many of the considerations for the mRNA manufacturing process.